NM_031407.7:c.10101G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_031407.7(HUWE1):​c.10101G>A​(p.Arg3367Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00989 in 1,208,499 control chromosomes in the GnomAD database, including 56 homozygotes. There are 3,820 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0072 ( 5 hom., 248 hem., cov: 23)
Exomes 𝑓: 0.010 ( 51 hom. 3572 hem. )

Consequence

HUWE1
NM_031407.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.01

Publications

2 publications found
Variant links:
Genes affected
HUWE1 (HGNC:30892): (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1) This gene encodes a protein containing a C-terminal HECT (E6AP type E3 ubiquitin protein ligase) domain that functions as an E3 ubiquitin ligase. The encoded protein is required for the ubiquitination and subsequent degradation of the anti-apoptotic protein Mcl1 (myeloid cell leukemia sequence 1 (BCL2-related)). This protein also ubiquitinates the p53 tumor suppressor, core histones, and DNA polymerase beta. Mutations in this gene are associated with Turner type X-linked syndromic cognitive disability. [provided by RefSeq, Aug 2013]
HUWE1 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked syndromic, Turner type
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics, G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.036).
BP6
Variant X-53548208-C-T is Benign according to our data. Variant chrX-53548208-C-T is described in ClinVar as Benign. ClinVar VariationId is 129248.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.01 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00717 (806/112452) while in subpopulation NFE AF = 0.0107 (572/53285). AF 95% confidence interval is 0.01. There are 5 homozygotes in GnomAd4. There are 248 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 806 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HUWE1NM_031407.7 linkc.10101G>A p.Arg3367Arg synonymous_variant Exon 68 of 84 ENST00000262854.11 NP_113584.3 Q7Z6Z7-1A0A024R9W5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HUWE1ENST00000262854.11 linkc.10101G>A p.Arg3367Arg synonymous_variant Exon 68 of 84 1 NM_031407.7 ENSP00000262854.6 Q7Z6Z7-1

Frequencies

GnomAD3 genomes
AF:
0.00717
AC:
806
AN:
112398
Hom.:
5
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00329
Gnomad ASJ
AF:
0.00188
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00367
Gnomad FIN
AF:
0.0232
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0107
Gnomad OTH
AF:
0.00397
GnomAD2 exomes
AF:
0.00773
AC:
1357
AN:
175555
AF XY:
0.00732
show subpopulations
Gnomad AFR exome
AF:
0.000863
Gnomad AMR exome
AF:
0.00258
Gnomad ASJ exome
AF:
0.00272
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0224
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.00791
GnomAD4 exome
AF:
0.0102
AC:
11147
AN:
1096047
Hom.:
51
Cov.:
31
AF XY:
0.00988
AC XY:
3572
AN XY:
361581
show subpopulations
African (AFR)
AF:
0.000834
AC:
22
AN:
26379
American (AMR)
AF:
0.00256
AC:
90
AN:
35108
Ashkenazi Jewish (ASJ)
AF:
0.00186
AC:
36
AN:
19325
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30167
South Asian (SAS)
AF:
0.00364
AC:
195
AN:
53557
European-Finnish (FIN)
AF:
0.0235
AC:
949
AN:
40432
Middle Eastern (MID)
AF:
0.00145
AC:
6
AN:
4130
European-Non Finnish (NFE)
AF:
0.0112
AC:
9436
AN:
840931
Other (OTH)
AF:
0.00897
AC:
413
AN:
46018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
460
920
1381
1841
2301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
346
692
1038
1384
1730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00717
AC:
806
AN:
112452
Hom.:
5
Cov.:
23
AF XY:
0.00716
AC XY:
248
AN XY:
34624
show subpopulations
African (AFR)
AF:
0.00116
AC:
36
AN:
30992
American (AMR)
AF:
0.00328
AC:
35
AN:
10663
Ashkenazi Jewish (ASJ)
AF:
0.00188
AC:
5
AN:
2657
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3570
South Asian (SAS)
AF:
0.00368
AC:
10
AN:
2720
European-Finnish (FIN)
AF:
0.0232
AC:
142
AN:
6132
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.0107
AC:
572
AN:
53285
Other (OTH)
AF:
0.00392
AC:
6
AN:
1532
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
29
58
87
116
145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00892
Hom.:
67
Bravo
AF:
0.00555

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 15, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Oct 16, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
9.4
DANN
Benign
0.68
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41306894; hg19: chrX-53575169; API